{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:21:46Z","timestamp":1792686106788,"version":"4.5.0"},"reference-count":56,"publisher":"IMR Press","issue":"7","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Key Projects of Scientific and Technological Research Plan of the Education Department of Hubei Province","award":["D20234402"],"award-info":[{"award-number":["D20234402"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Background:The NOD-like receptor Family, pyrin domain-containing 3 protein (NLRP3) inflammasome is a macromolecular complex critical for inflammatory responses. Its excessive activation or improper regulation is intimately associated with the development of various inflammatory diseases. However, currently available drugs directly targeting the NLRP3 inflammasome are limited. In preliminary analyses, detecting the level of secreted interleukin-1 beta (IL-1\u03b2) revealed that betamethasone-17,21-dipropionate (also known as betamethasone dipropionate, BD), a clinically used glucocorticoid, potentially inhibits NLRP3 inflammasome activation.Methods:In vitro, the role and preliminary mechanism of BD in inhibiting the activation of NLRP3 inflammasome were investigated in THP-1-differentiated macrophages and bone marrow-derived macrophages (BMDMs) using enzyme-linked immunosorbent assay (ELISA), Cell Counting Kit-8 (CCK-8), reverse transcription-quantitative polymerase chain reaction (RT-qPCR), and western blotting (WB). The preliminary effects of BD on the assembly of NLRP3 inflammasome were assessed in HEK293T cells overexpressing NLRP3\/ASC\/caspase-1\/NEK7 through drug affinity responsive target stability (DARTS) and co-immunoprecipitation (Co-IP) approaches. In vivo, the effect of BD on LPS-induced systemic inflammation was assessed by measuring serum concentrations of IL-1\u03b2 and TNF-\u03b1 via ELISA, and by recording mouse survival rates and body weights.Results:BD significantly inhibited NLRP3 inflammasome activation by suppressing pro-IL-1\u03b2 expression in vitro. Mechanistic studies showed that it decreased pro-IL-1\u03b2 expression by suppressing NF-\u03baB signaling. In vivo, BD downregulated the serum concentrations of IL-1\u03b2 and TNF-\u03b1, and increase the survival rate of mice using the LPS-induced systemic inflammation model.Conclusions:Collectively, our data verify that BD inhibits NLRP3 inflammasome activation by suppressing pro-IL-1\u03b2 expression. These findings suggest that BD may be a potential therapeutic approach for inflammatory diseases. However, further studies are needed to elucidate its precise role and specific mechanism in clinical practice.<\/jats:p>","DOI":"10.31083\/fbl51536","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:17:49Z","timestamp":1785413869000},"source":"Crossref","is-referenced-by-count":1,"title":["Betamethasone Dipropionate Inhibits NLRP3 Inflammasome Activation by Suppressing Pro-IL-1\u03b2 Expression"],"prefix":"10.31083","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9405-0785","authenticated-orcid":true,"given":"Weichen","family":"Huang","sequence":"first","affiliation":[{"name":"Institute of Biomedical Sciences, School of Medicine, Jianghan University, 430056 Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6914-4445","authenticated-orcid":true,"given":"Shoufeng","family":"Xie","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Sciences, School of Medicine, Jianghan University, 430056 Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1625-5185","authenticated-orcid":true,"given":"Xinyu","family":"Rong","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Sciences, School of Medicine, Jianghan University, 430056 Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5721-0927","authenticated-orcid":true,"given":"Yongzhi","family":"Liu","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Sciences, School of Medicine, Jianghan University, 430056 Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3708-0273","authenticated-orcid":true,"given":"Weiling","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Sciences, School of Medicine, Jianghan University, 430056 Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2162-4757","authenticated-orcid":true,"given":"Qian","family":"Peng","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Sciences, School of Medicine, Jianghan University, 430056 Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3840-5428","authenticated-orcid":true,"given":"Song","family":"Hu","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Sciences, School of Medicine, Jianghan University, 430056 Wuhan, Hubei, China"},{"name":"Department of Pathogenic Biology, School of Medicine, Jianghan University, 430056 Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4456-740X","authenticated-orcid":true,"given":"Binlian","family":"Sun","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Sciences, School of Medicine, Jianghan University, 430056 Wuhan, Hubei, China"},{"name":"Department of Immunology, School of Medicine, Jianghan University, 430056 Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5374-2356","authenticated-orcid":true,"given":"Pin","family":"Wan","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Sciences, School of Medicine, Jianghan University, 430056 Wuhan, Hubei, China"},{"name":"Department of Immunology, School of Medicine, Jianghan University, 430056 Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Fu J, Schroder K, Wu H. Mechanistic insights from inflammasome structures. Nature Reviews. Immunology. 2024; 24: 518\u2013535.","DOI":"10.1038\/s41577-024-00995-w"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Barnett KC, Li S, Liang K, Ting JPY. A 360\u00b0 view of the inflammasome: Mechanisms of activation, cell death, and diseases. Cell. 2023; 186: 2288\u20132312.","DOI":"10.1016\/j.cell.2023.04.025"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Yue Z, Zhang X, Gu Y, Liu Y, Lan LM, Liu Y, et al. Regulation and functions of the NLRP3 inflammasome in RNA virus infection. Frontiers in Cellular and Infection Microbiology. 2024; 13: 1309128.","DOI":"10.3389\/fcimb.2023.1309128"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Swanson KV, Deng M, Ting JPY. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nature Reviews. Immunology. 2019; 19: 477\u2013489.","DOI":"10.1038\/s41577-019-0165-0"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Chen Y, Ye X, Escames G, Lei W, Zhang X, Li M, et al. The NLRP3 inflammasome: contributions to inflammation-related diseases. Cellular & Molecular Biology Letters. 2023; 28: 51.","DOI":"10.1186\/s11658-023-00462-9"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Xu W, Huang Y, Zhou R. NLRP3 inflammasome in neuroinflammation and central nervous system diseases. Cellular & Molecular Immunology. 2025; 22: 341\u2013355.","DOI":"10.1038\/s41423-025-01275-w"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Carnazzo V, Rigante D, Restante G, Basile V, Pocino K, Basile U. The entrenchment of NLRP3 inflammasomes in autoimmune disease-related inflammation. Autoimmunity Reviews. 2025; 24: 103815.","DOI":"10.1016\/j.autrev.2025.103815"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"He W, Dong H, Wu C, Zhong Y, Li J. The role of NLRP3 inflammasome in sepsis: A potential therapeutic target. International Immunopharmacology. 2023; 115: 109697.","DOI":"10.1016\/j.intimp.2023.109697"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Sharma BR, Kanneganti TD. NLRP3 inflammasome in cancer and metabolic diseases. Nature Immunology. 2021; 22: 550\u2013559.","DOI":"10.1038\/s41590-021-00886-5"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"de Carvalho Ribeiro M, Szabo G. Role of the Inflammasome in Liver Disease. Annual Review of Pathology. 2022; 17: 345\u2013365.","DOI":"10.1146\/annurev-pathmechdis-032521-102529"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Chen P, Li X. NLRP3 inflammasome in atherosclerosis: Mechanisms and targeted therapies. Frontiers in Pharmacology. 2024; 15: 1430236.","DOI":"10.3389\/fphar.2024.1430236"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Zudeh G, Sossai S, Angelini J, Stocco G, Lucaf\u00f2 M. Pharmacological Modulation of NLRP3: From Therapy Personalization to Innovative Drugs. Frontiers in Bioscience (Landmark Edition). 2025; 30: 39537.","DOI":"10.31083\/FBL39537"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Huang Y, Xu W, Zhou R. NLRP3 inflammasome activation and cell death. Cellular & Molecular Immunology. 2021; 18: 2114\u20132127.","DOI":"10.1038\/s41423-021-00740-6"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Accogli T, Hibos C, Vegran F. Canonical and non-canonical functions of NLRP3. Journal of Advanced Research. 2023; 53: 137\u2013151.","DOI":"10.1016\/j.jare.2023.01.001"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Jo EK, Kim JK, Shin DM, Sasakawa C. Molecular mechanisms regulating NLRP3 inflammasome activation. Cellular & Molecular Immunology. 2016; 13: 148\u2013159.","DOI":"10.1038\/cmi.2015.95"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"O'Keefe ME, Dubyak GR, Abbott DW. Post-translational control of NLRP3 inflammasome signaling. The Journal of Biological Chemistry. 2024; 300: 107386.","DOI":"10.1016\/j.jbc.2024.107386"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Vande Walle L, Lamkanfi M. Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets. Nature Reviews. Drug Discovery. 2024; 23: 43\u201366.","DOI":"10.1038\/s41573-023-00822-2"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Beesetti S. Ubiquitin Ligases in Control: Regulating NLRP3 Inflammasome Activation. Frontiers in Bioscience (Landmark Edition). 2025; 30: 25970.","DOI":"10.31083\/FBL25970"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Schroder K, Tschopp J. The inflammasomes. Cell. 2010; 140: 821\u2013832.","DOI":"10.1016\/j.cell.2010.01.040"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Paik S, Kim JK, Silwal P, Sasakawa C, Jo EK. An update on the regulatory mechanisms of NLRP3 inflammasome activation. Cellular & Molecular Immunology. 2021; 18: 1141\u20131160.","DOI":"10.1038\/s41423-021-00670-3"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Sharif H, Wang L, Wang WL, Magupalli VG, Andreeva L, Qiao Q, et al. Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome. Nature. 2019; 570: 338\u2013343.","DOI":"10.1038\/s41586-019-1295-z"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"He Y, Zeng MY, Yang D, Motro B, N\u00fa\u00f1ez G. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature. 2016; 530: 354\u2013357.","DOI":"10.1038\/nature16959"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"He H, Jiang H, Chen Y, Ye J, Wang A, Wang C, et al. Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity. Nature Communications. 2018; 9: 2550.","DOI":"10.1038\/s41467-018-04947-6"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Shao JJ, Li WF, Sun JF, Zhuang ZS, Min JL, Long XH, et al. Britannin as a novel NLRP3 inhibitor, suppresses inflammasome activation in macrophages and alleviates NLRP3-related diseases in mice. Acta Pharmacologica Sinica. 2024; 45: 803\u2013814.","DOI":"10.1038\/s41401-023-01212-5"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Coll RC, Hill JR, Day CJ, Zamoshnikova A, Boucher D, Massey NL, et al. MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition. Nature Chemical Biology. 2019; 15: 556\u2013559.","DOI":"10.1038\/s41589-019-0277-7"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Jin X, Liu D, Zhou X, Luo X, Huang Q, Huang Y. Entrectinib inhibits NLRP3 inflammasome and inflammatory diseases by directly targeting NEK7. Cell Reports. Medicine. 2023; 4: 101310.","DOI":"10.1016\/j.xcrm.2023.101310"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Zeng Q, Deng H, Li Y, Fan T, Liu Y, Tang S, et al. Berberine Directly Targets the NEK7 Protein to Block the NEK7-NLRP3 Interaction and Exert Anti-inflammatory Activity. Journal of Medicinal Chemistry. 2021; 64: 768\u2013781.","DOI":"10.1021\/acs.jmedchem.0c01743"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Rathkey JK, Zhao J, Liu Z, Chen Y, Yang J, Kondolf HC, et al. Chemical disruption of the pyroptotic pore-forming protein gasdermin D inhibits inflammatory cell death and sepsis. Science Immunology. 2018; 3: eaat2738.","DOI":"10.1126\/sciimmunol.aat2738"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Zhuang L, Luo X, Wu S, Lin Z, Zhang Y, Zhai Z, et al. Disulfiram alleviates pristane-induced lupus via inhibiting GSDMD-mediated pyroptosis. Cell Death Discovery. 2022; 8: 379.","DOI":"10.1038\/s41420-022-01167-2"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Ye L, Huang W, Li W, Yao Y, Peng Q, Fu Z, et al. Loteprednol etabonate alleviates NLRP3 inflammasome-associated inflammatory diseases in mice by suppressing the transcription of IL-1\u03b2. International Journal of Biological Macromolecules. 2025; 306: 141644.","DOI":"10.1016\/j.ijbiomac.2025.141644"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Ren B, Feng J, Yang N, Guo Y, Chen C, Qin Q. Ginsenoside Rg3 attenuates angiotensin II-induced myocardial hypertrophy through repressing NLRP3 inflammasome and oxidative stress via modulating SIRT1\/NF-\u03baB pathway. International Immunopharmacology. 2021; 98: 107841.","DOI":"10.1016\/j.intimp.2021.107841"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Gallo L, Megna M, Cirillo T, Caterino P, Lodi G, Mozzillo R, et al. Psoriasis and skin pain: real-life effectiveness of calcipotriol plus betamethasone dipropionate in aerosol foam formulation. Journal of the European Academy of Dermatology and Venereology : JEADV. 2019; 33: 1312\u20131315.","DOI":"10.1111\/jdv.15488"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Fujiyama T, Ito T, Umayahara T, Ikeya S, Tatsuno K, Funakoshi A, et al. Topical application of a vitamin D3 analogue and corticosteroid to psoriasis plaques decreases skin infiltration of TH17 cells and their ex vivo expansion. The Journal of Allergy and Clinical Immunology. 2016; 138: 517\u2013528.e5.","DOI":"10.1016\/j.jaci.2016.03.048"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Li W, Qiao J, You Q, Zong S, Peng Q, Liu Y, et al. SARS-CoV-2 Nsp5 Activates NF-\u03baB Pathway by Upregulating SUMOylation of MAVS. Frontiers in Immunology. 2021; 12: 750969.","DOI":"10.3389\/fimmu.2021.750969"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Zong S, Wu Y, Li W, You Q, Peng Q, Wang C, et al. SARS-CoV-2 Nsp8 induces mitophagy by damaging mitochondria. Virologica Sinica. 2023; 38: 520\u2013530.","DOI":"10.1016\/j.virs.2023.05.003"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Danielski LG, Giustina AD, Bonfante S, Barichello T, Petronilho F. The NLRP3 Inflammasome and Its Role in Sepsis Development. Inflammation. 2020; 43: 24\u201331.","DOI":"10.1007\/s10753-019-01124-9"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M, et al. NF-\u03baB in biology and targeted therapy: new insights and translational implications. Signal Transduction and Targeted Therapy. 2024; 9: 53.","DOI":"10.1038\/s41392-024-01757-9"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Wang L, Cai J, Zhao X, Ma L, Zeng P, Zhou L, et al. Palmitoylation prevents sustained inflammation by limiting NLRP3 inflammasome activation through chaperone-mediated autophagy. Molecular Cell. 2023; 83: 281\u2013297.e10.","DOI":"10.1016\/j.molcel.2022.12.002"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Li YF, Sheng HD, Qian J, Wang Y. The Chinese medicine babaodan suppresses LPS-induced sepsis by inhibiting NLRP3-mediated inflammasome activation. Journal of Ethnopharmacology. 2022; 292: 115205.","DOI":"10.1016\/j.jep.2022.115205"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Liang S, Zhou J, Cao C, Liu Y, Ming S, Liu X, et al. GITR exacerbates lysophosphatidylcholine-induced macrophage pyroptosis in sepsis via posttranslational regulation of NLRP3. Cellular & Molecular Immunology. 2024; 21: 674\u2013688.","DOI":"10.1038\/s41423-024-01170-w"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Genito CJ, Eckshtain-Levi M, Piedra-Quintero ZL, Krovi SA, Kroboth A, Stiepel RT, et al. Dexamethasone and Fumaric Acid Ester Conjugate Synergistically Inhibits Inflammation and NF-\u03baB in Macrophages. Bioconjugate Chemistry. 2021; 32: 1629\u20131640.","DOI":"10.1021\/acs.bioconjchem.1c00200"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Wang S, Fan M, Zou Z, Deng J. Dexamethasone regulates the SIRT1\/NF-\u03baB signaling pathway in neonatal rats with bronchopulmonary dysplasia to counteract NLRP3-inflammasome-induced pyroptosis and oxidative stress. Chemico-biological Interactions. 2026; 424: 111882.","DOI":"10.1016\/j.cbi.2025.111882"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Koerber RM, Oberbeck S, Kotthoff P, Daecke SN, Brossart P, Held SAE. Dexamethasone induced Dectin-1 activation enhances NLRP3 inflammasome activation. Frontiers in Immunology. 2025; 16: 1656288.","DOI":"10.3389\/fimmu.2025.1656288"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Zhao W, Ma L, Cai C, Gong X. Caffeine Inhibits NLRP3 Inflammasome Activation by Suppressing MAPK\/NF-\u03baB and A2aR Signaling in LPS-Induced THP-1 Macrophages. International Journal of Biological Sciences. 2019; 15: 1571\u20131581.","DOI":"10.7150\/ijbs.34211"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Kaszycki J, Kim M. Epigenetic regulation of transcription factors involved in NLRP3 inflammasome and NF-kB signaling pathways. Frontiers in Immunology. 2025; 16: 1529756.","DOI":"10.3389\/fimmu.2025.1529756"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Bansal A, Kooi C, Kalyanaraman K, Gill S, Thorne A, Chandramohan P, et al. Synergy between Interleukin-1\u03b2, Interferon-\u03b3, and Glucocorticoids to Induce TLR2 Expression Involves NF-\u03baB, STAT1, and the Glucocorticoid Receptor. Molecular Pharmacology. 2023; 105: 23\u201338.","DOI":"10.1124\/molpharm.123.000740"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"He Y, Hara H, N\u00fa\u00f1ez G. Mechanism and Regulation of NLRP3 Inflammasome Activation. Trends in Biochemical Sciences. 2016; 41: 1012\u20131021.","DOI":"10.1016\/j.tibs.2016.09.002"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Cabral JE, Wu A, Zhou H, Pham MA, Lin S, McNulty R. Targeting the NLRP3 inflammasome for inflammatory disease therapy. Trends in Pharmacological Sciences. 2025; 46: 503\u2013519.","DOI":"10.1016\/j.tips.2025.04.007"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Wan P, Zhang S, Ruan Z, Liu X, Yang G, Jia Y, et al. AP-1 signaling pathway promotes pro-IL-1\u03b2 transcription to facilitate NLRP3 inflammasome activation upon influenza A virus infection. Virulence. 2022; 13: 502\u2013513.","DOI":"10.1080\/21505594.2022.2040188"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Duong BH, Onizawa M, Oses-Prieto JA, Advincula R, Burlingame A, Malynn BA, et al. A20 restricts ubiquitination of pro-interleukin-1\u03b2 protein complexes and suppresses NLRP3 inflammasome activity. Immunity. 2015; 42: 55\u201367.","DOI":"10.1016\/j.immuni.2014.12.031"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Zhu S, Liao L, Zhong Y, Liu Z, Lu J, Yang Z, et al. Hepatocellular CMPK2 promotes the development of metabolic dysfunction-associated steatohepatitis. Journal of Hepatology. 2025; 83: 383\u2013396.","DOI":"10.1016\/j.jhep.2025.01.008"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Zhong P, Peng C, Liang YH, Huang HC, Wang P, Yang M, et al. 1,2,4-Trimethoxybenzene alleviates cognitive dysfunction in type 2 diabetes model rats by inhibiting NLRP3 inflammasome and restoring gut microbiota disorders. Biochemical Pharmacology. 2025; 242: 117409.","DOI":"10.1016\/j.bcp.2025.117409"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Fabbrocini G, De Simone C, Dapavo P, Malagoli P, Martella A, Calzavara-Pinton P. Long-term maintenance treatment of psoriasis: the role of calcipotriol\/betamethasone dipropionate aerosol foam in clinical practice. The Journal of Dermatological Treatment. 2022; 33: 2425\u20132432.","DOI":"10.1080\/09546634.2021.1998310"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Li J, Yuan Z, Shi S, Chen X, Yu S, Qi X, et al. Microneedle patches incorporating zinc-doped mesoporous silica nanoparticles loaded with betamethasone dipropionate for psoriasis treatment. Journal of Nanobiotechnology. 2024; 22: 706.","DOI":"10.1186\/s12951-024-02986-4"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Satake K, Amano T, Okamoto T. Calcipotriol and betamethasone dipropionate synergistically enhances the balance between regulatory and proinflammatory T cells in a murine psoriasis model. Scientific Reports. 2019; 9: 16322.","DOI":"10.1038\/s41598-019-52892-1"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"Lovato P, Norsgaard H, Tokura Y, R\u00f8pke MA. Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis. Journal of Dermatological Science. 2016; 81: 153\u2013164.","DOI":"10.1016\/j.jdermsci.2015.12.009"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/7\/10.31083\/FBL51536","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:18:56Z","timestamp":1785413936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/7\/10.31083\/FBL51536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2768-6701(26)02163-5"],"URL":"https:\/\/doi.org\/10.31083\/fbl51536","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"article-number":"51536"}}